Department of Biotechnology, Quaid-i-Azam University, Islamabad, Pakistan.
Department of Bioinformatics, Quaid-i-Azam University, Islamabad, Pakistan.
Infect Genet Evol. 2018 Apr;59:51-62. doi: 10.1016/j.meegid.2018.01.026. Epub 2018 Jan 31.
The nonstructural protein 3 (NS3) helicase of HCV is believed to be a plausible target for the identification and designing of potent antiviral drugs. NS3 protein is involved in a positive sense single-stranded viral replication as well as it also cleaves viral poly protein into diverse mature proteins at different time spans. Structural exploration of NS3 revealed that HCV helicase could also act as translocase. In order to identify potential inhibitors for HCV-3a, the current study has been designed. Serum samples from the Pakistani HCV positive patients were collected, sequenced and after purification included in the present study. Phylogenetic analysis on the samples clustered around it in the same group with those from India. Using homology modeling technique, we determined 3D structure of NS3 gene of HCV-3a and employed further in docking studies to discover potent inhibitor against it. As a result of docking Compound 1, with IC50 value of 0.015 and -14.4 kcal/mol energy, ranked as a most pungent inhibitor among all the studied inhibitors. Compound 1 also exhibited good hydrogen bond interactions with the modeled protein. The finding of present study could be used as a lead in future to design an effective dual inhibitor against HCV-3a.
丙型肝炎病毒(HCV)的非结构蛋白 3(NS3)解旋酶被认为是鉴定和设计有效抗病毒药物的合理靶点。NS3 蛋白参与正链单链病毒复制,还在不同时间段将病毒多蛋白切割成多种成熟蛋白。对 NS3 的结构研究表明,HCV 解旋酶也可以作为转位酶。为了鉴定 HCV-3a 的潜在抑制剂,设计了本研究。收集了来自巴基斯坦 HCV 阳性患者的血清样本,进行测序并在纯化后包含在本研究中。对样本进行系统发育分析,结果显示它们与来自印度的样本聚类在同一组。使用同源建模技术,我们确定了 HCV-3a 的 NS3 基因的 3D 结构,并进一步用于对接研究,以发现针对它的有效抑制剂。对接结果表明,化合物 1 的 IC50 值为 0.015,能量为-14.4 kcal/mol,是所有研究抑制剂中最有效的抑制剂之一。化合物 1 还与模型蛋白表现出良好的氢键相互作用。本研究的发现可作为未来设计有效 HCV-3a 双重抑制剂的先导。